Non-infectious Macular Edema Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: N50280237229EN
Market Monitor Global

Abstracts

Non-infectious Macular Edema Treatment refers to the treatment of Non-infectious Macular Edema by drugs or therapies such as anti-VEGF therapy, corticosteroids, immunosuppressive agents, and biological agents. The macula is a region of the center of the retina. Macular edema is the accumulation of fluid in the macula that causes the macula to swell and thicken, thereby distorting vision.

This report contains market size and forecasts of Non-infectious Macular Edema Treatment in Global, including the following market information:

Global Non-infectious Macular Edema Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Non-infectious Macular Edema Treatment market was valued at 11150 million in 2021 and is projected to reach US$ 15370 million by 2028, at a CAGR of 4.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anti-VEGF Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non-infectious Macular Edema Treatment include Allergan, Amgen, Pfizer, Novartis AG, F. Hoffman-La Roche, AbbVie, Bayer AG, Valeant Pharmaceuticals and Alimera Sciences and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-infectious Macular Edema Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-infectious Macular Edema Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Non-infectious Macular Edema Treatment Market Segment Percentages, by Type, 2021 (%)

• Anti-VEGF Therapy
• Corticosteroid
• Immune Inhibitor
• Biological Preparation
• Other

Global Non-infectious Macular Edema Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Non-infectious Macular Edema Treatment Market Segment Percentages, by Application, 2021 (%)

• Retail Pharmacy
• Hospital Pharmacy
• Other

Global Non-infectious Macular Edema Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Non-infectious Macular Edema Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non-infectious Macular Edema Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Non-infectious Macular Edema Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Amgen
• Pfizer
• Novartis AG
• F. Hoffman-La Roche
• AbbVie
• Bayer AG
• Valeant Pharmaceuticals
• Alimera Sciences
• Clearside Biomedical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Non-infectious Macular Edema Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Non-infectious Macular Edema Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NON-INFECTIOUS MACULAR EDEMA TREATMENT OVERALL MARKET SIZE

2.1 Global Non-infectious Macular Edema Treatment Market Size: 2021 VS 2028
2.2 Global Non-infectious Macular Edema Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Non-infectious Macular Edema Treatment Players in Global Market
3.2 Top Global Non-infectious Macular Edema Treatment Companies Ranked by Revenue
3.3 Global Non-infectious Macular Edema Treatment Revenue by Companies
3.4 Top 3 and Top 5 Non-infectious Macular Edema Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non-infectious Macular Edema Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-infectious Macular Edema Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Non-infectious Macular Edema Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Non-infectious Macular Edema Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Non-infectious Macular Edema Treatment Market Size Markets, 2021 & 2028
  4.1.2 Anti-VEGF Therapy
  4.1.3 Corticosteroid
  4.1.4 Immune Inhibitor
  4.1.5 Biological Preparation
  4.1.6 Other
4.2 By Type - Global Non-infectious Macular Edema Treatment Revenue & Forecasts
  4.2.1 By Type - Global Non-infectious Macular Edema Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Non-infectious Macular Edema Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Non-infectious Macular Edema Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Non-infectious Macular Edema Treatment Market Size, 2021 & 2028
  5.1.2 Retail Pharmacy
  5.1.3 Hospital Pharmacy
  5.1.4 Other
5.2 By Application - Global Non-infectious Macular Edema Treatment Revenue & Forecasts
  5.2.1 By Application - Global Non-infectious Macular Edema Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Non-infectious Macular Edema Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Non-infectious Macular Edema Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Non-infectious Macular Edema Treatment Market Size, 2021 & 2028
6.2 By Region - Global Non-infectious Macular Edema Treatment Revenue & Forecasts
  6.2.1 By Region - Global Non-infectious Macular Edema Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Non-infectious Macular Edema Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Non-infectious Macular Edema Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Non-infectious Macular Edema Treatment Revenue, 2017-2028
  6.3.2 US Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.3.3 Canada Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.3.4 Mexico Non-infectious Macular Edema Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Non-infectious Macular Edema Treatment Revenue, 2017-2028
  6.4.2 Germany Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.4.3 France Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.4.4 U.K. Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.4.5 Italy Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.4.6 Russia Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.4.8 Benelux Non-infectious Macular Edema Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Non-infectious Macular Edema Treatment Revenue, 2017-2028
  6.5.2 China Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.5.3 Japan Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.5.4 South Korea Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.5.6 India Non-infectious Macular Edema Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Non-infectious Macular Edema Treatment Revenue, 2017-2028
  6.6.2 Brazil Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.6.3 Argentina Non-infectious Macular Edema Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Non-infectious Macular Edema Treatment Revenue, 2017-2028
  6.7.2 Turkey Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.7.3 Israel Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Non-infectious Macular Edema Treatment Market Size, 2017-2028
  6.7.5 UAE Non-infectious Macular Edema Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan
  7.1.1 Allergan Corporate Summary
  7.1.2 Allergan Business Overview
  7.1.3 Allergan Non-infectious Macular Edema Treatment Major Product Offerings
  7.1.4 Allergan Non-infectious Macular Edema Treatment Revenue in Global Market (2017-2022)
  7.1.5 Allergan Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Non-infectious Macular Edema Treatment Major Product Offerings
  7.2.4 Amgen Non-infectious Macular Edema Treatment Revenue in Global Market (2017-2022)
  7.2.5 Amgen Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Non-infectious Macular Edema Treatment Major Product Offerings
  7.3.4 Pfizer Non-infectious Macular Edema Treatment Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Novartis AG
  7.4.1 Novartis AG Corporate Summary
  7.4.2 Novartis AG Business Overview
  7.4.3 Novartis AG Non-infectious Macular Edema Treatment Major Product Offerings
  7.4.4 Novartis AG Non-infectious Macular Edema Treatment Revenue in Global Market (2017-2022)
  7.4.5 Novartis AG Key News
7.5 F. Hoffman-La Roche
  7.5.1 F. Hoffman-La Roche Corporate Summary
  7.5.2 F. Hoffman-La Roche Business Overview
  7.5.3 F. Hoffman-La Roche Non-infectious Macular Edema Treatment Major Product Offerings
  7.5.4 F. Hoffman-La Roche Non-infectious Macular Edema Treatment Revenue in Global Market (2017-2022)
  7.5.5 F. Hoffman-La Roche Key News
7.6 AbbVie
  7.6.1 AbbVie Corporate Summary
  7.6.2 AbbVie Business Overview
  7.6.3 AbbVie Non-infectious Macular Edema Treatment Major Product Offerings
  7.6.4 AbbVie Non-infectious Macular Edema Treatment Revenue in Global Market (2017-2022)
  7.6.5 AbbVie Key News
7.7 Bayer AG
  7.7.1 Bayer AG Corporate Summary
  7.7.2 Bayer AG Business Overview
  7.7.3 Bayer AG Non-infectious Macular Edema Treatment Major Product Offerings
  7.7.4 Bayer AG Non-infectious Macular Edema Treatment Revenue in Global Market (2017-2022)
  7.7.5 Bayer AG Key News
7.8 Valeant Pharmaceuticals
  7.8.1 Valeant Pharmaceuticals Corporate Summary
  7.8.2 Valeant Pharmaceuticals Business Overview
  7.8.3 Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Major Product Offerings
  7.8.4 Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Revenue in Global Market (2017-2022)
  7.8.5 Valeant Pharmaceuticals Key News
7.9 Alimera Sciences
  7.9.1 Alimera Sciences Corporate Summary
  7.9.2 Alimera Sciences Business Overview
  7.9.3 Alimera Sciences Non-infectious Macular Edema Treatment Major Product Offerings
  7.9.4 Alimera Sciences Non-infectious Macular Edema Treatment Revenue in Global Market (2017-2022)
  7.9.5 Alimera Sciences Key News
7.10 Clearside Biomedical
  7.10.1 Clearside Biomedical Corporate Summary
  7.10.2 Clearside Biomedical Business Overview
  7.10.3 Clearside Biomedical Non-infectious Macular Edema Treatment Major Product Offerings
  7.10.4 Clearside Biomedical Non-infectious Macular Edema Treatment Revenue in Global Market (2017-2022)
  7.10.5 Clearside Biomedical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Non-infectious Macular Edema Treatment Market Opportunities & Trends in Global Market
Table 2. Non-infectious Macular Edema Treatment Market Drivers in Global Market
Table 3. Non-infectious Macular Edema Treatment Market Restraints in Global Market
Table 4. Key Players of Non-infectious Macular Edema Treatment in Global Market
Table 5. Top Non-infectious Macular Edema Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non-infectious Macular Edema Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non-infectious Macular Edema Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non-infectious Macular Edema Treatment Product Type
Table 9. List of Global Tier 1 Non-infectious Macular Edema Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-infectious Macular Edema Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non-infectious Macular Edema Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non-infectious Macular Edema Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non-infectious Macular Edema Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non-infectious Macular Edema Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non-infectious Macular Edema Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non-infectious Macular Edema Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Corporate Summary
Table 31. Allergan Non-infectious Macular Edema Treatment Product Offerings
Table 32. Allergan Non-infectious Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Non-infectious Macular Edema Treatment Product Offerings
Table 35. Amgen Non-infectious Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Non-infectious Macular Edema Treatment Product Offerings
Table 38. Pfizer Non-infectious Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Non-infectious Macular Edema Treatment Product Offerings
Table 41. Novartis AG Non-infectious Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 42. F. Hoffman-La Roche Corporate Summary
Table 43. F. Hoffman-La Roche Non-infectious Macular Edema Treatment Product Offerings
Table 44. F. Hoffman-La Roche Non-infectious Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 45. AbbVie Corporate Summary
Table 46. AbbVie Non-infectious Macular Edema Treatment Product Offerings
Table 47. AbbVie Non-infectious Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Bayer AG Corporate Summary
Table 49. Bayer AG Non-infectious Macular Edema Treatment Product Offerings
Table 50. Bayer AG Non-infectious Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Valeant Pharmaceuticals Corporate Summary
Table 52. Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Product Offerings
Table 53. Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Alimera Sciences Corporate Summary
Table 55. Alimera Sciences Non-infectious Macular Edema Treatment Product Offerings
Table 56. Alimera Sciences Non-infectious Macular Edema Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Clearside Biomedical Corporate Summary
Table 58. Clearside Biomedical Non-infectious Macular Edema Treatment Product Offerings
Table 59. Clearside Biomedical Non-infectious Macular Edema Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Non-infectious Macular Edema Treatment Segment by Type in 2021
Figure 2. Non-infectious Macular Edema Treatment Segment by Application in 2021
Figure 3. Global Non-infectious Macular Edema Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-infectious Macular Edema Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-infectious Macular Edema Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-infectious Macular Edema Treatment Revenue in 2021
Figure 8. By Type - Global Non-infectious Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non-infectious Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non-infectious Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non-infectious Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 12. US Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non-infectious Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non-infectious Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 24. China Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non-infectious Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non-infectious Macular Edema Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non-infectious Macular Edema Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Non-infectious Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Non-infectious Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Non-infectious Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis AG Non-infectious Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. F. Hoffman-La Roche Non-infectious Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AbbVie Non-infectious Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer AG Non-infectious Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Alimera Sciences Non-infectious Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Clearside Biomedical Non-infectious Macular Edema Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)